Center-Authored Papers
Filters: Author is Skates, Steven J [Clear All Filters]
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.. Nature biotechnology. 27(7):633-41. Abstract
.
2009.
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.. Cancer prevention research (Philadelphia, Pa.). 4(3):365-74. Abstract
.
2011.
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status.. Cancer prevention research (Philadelphia, Pa.). 4(9):1401-8. Abstract
.
2011.
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.. Cancer prevention research (Philadelphia, Pa.). 4(3):375-83. Abstract
.
2011.
Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma.. Molecular & cellular proteomics : MCP. 11(6):M111.013854. Abstract
.
2012.
Design, Implementation, and Multi-Site Evaluation of a System Suitability Protocol for the Quantitative Assessment of Instrument Performance in LC-MRM-MS.. Molecular & cellular proteomics : MCP. Abstract
.
2013.
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.. Cancer prevention research (Philadelphia, Pa.). 4(3):365-74. Abstract
.
2011.
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.. Cancer prevention research (Philadelphia, Pa.). 4(3):375-83. Abstract
.
2011.
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.. Cancer prevention research (Philadelphia, Pa.). 4(3):365-74. Abstract
.
2011.
Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma.. Molecular & cellular proteomics : MCP. 11(6):M111.013854. Abstract
.
2012.
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.. Cancer prevention research (Philadelphia, Pa.). 4(3):375-83. Abstract
.
2011.
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.. Cancer prevention research (Philadelphia, Pa.). 4(3):365-74. Abstract
.
2011.
Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma.. Molecular & cellular proteomics : MCP. 11(6):M111.013854. Abstract
.
2012.
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.. Nature biotechnology. 27(7):633-41. Abstract
.
2009.
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.. Cancer prevention research (Philadelphia, Pa.). 4(3):375-83. Abstract
.
2011.
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.. Cancer prevention research (Philadelphia, Pa.). 4(3):365-74. Abstract
.
2011.
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.. Nature biotechnology. 27(7):633-41. Abstract
.
2009.
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.. Nature biotechnology. 27(7):633-41. Abstract
.
2009.
Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma.. Molecular & cellular proteomics : MCP. 11(6):M111.013854. Abstract
.
2012.
Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.. Journal of the National Cancer Institute. 107(4) Abstract
.
2015.
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.. Cancer prevention research (Philadelphia, Pa.). 4(3):375-83. Abstract
.
2011.
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.. Cancer prevention research (Philadelphia, Pa.). 4(3):375-83. Abstract
.
2011.
Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma.. Molecular & cellular proteomics : MCP. 11(6):M111.013854. Abstract
.
2012.
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status.. Cancer prevention research (Philadelphia, Pa.). 4(9):1401-8. Abstract
.
2011.
Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma.. Molecular & cellular proteomics : MCP. 11(6):M111.013854. Abstract
.
2012. Doing Business with Arnold Library
Weintraub Building, B1-010
(206) 667-4314
library@fredhutch.org
More About Arnold Library
Quick Links
- ILLiad/ILL Form
- Journals List
- Ovid - Medline
- Web of Science
- Pubmed
- Libguides
- Library Catalog
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Papers (Intranet)